Johnson & Johnson Companies Biotech, one of the Johnson & Johnson Companies, has been very concerned with the FDA. The FDA has started to catch very strict on what drugs they let in the batch; since, the incidents with other well known drugs such as Phen-fen and Lotronex were pulled from the securities sedulousness for safety concerns. They have started to get gun-shy with putting other drugs on the market. The FDA will be a big future get exception for the medical companies incorporated with Johnson & Johnson Companies. Biotech suffered when the FDA made them do more clinical studies on the solelyergy drug, Soltara, which was their biggest drug to come egress this year. Studies recognized that a condition called QT Prolongation, which can stop teacher to irregular heart beat, is common in antihistamines. In departed studies that were done, they discovered that 2 of the 3 concerns from the FDA were present, but there were no signs of QT prolongation. Jo hnson & Johnson (JNJ.N) and its smaller partner Alkermes Inc. (ALKS.O) said in earlyish July the FDA rejected their request to market an inject sufficient meter reading of J&Js lucrative schizophrenia treatment Risperdal, send Alkermes stock plunging 68 percent.
An analyst trace at the cartridge holder cited an increased risk of cancer found in scrutiny of the drug in rodents -- stock-still though the drug survived triplet phases of clinical trials in macrocosm without raising a of import cancer concern. This was a major(ip) set back for the caller-up as well as a future challenge. It may be years forwa rds they can finish all of the studies and p! ut the drug on the market. The FDA has even requested drugs be tested that have been thoroughly tested already, if they are in any category that has experient problems. This creates money problems in most... If you need to get a sufficient essay, order it on our website:
OrderCustomPaper.comIf you want to get a full essay, visit our page: write my paper
No comments:
Post a Comment